<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01721421</url>
  </required_header>
  <id_info>
    <org_study_id>11-LL-0505</org_study_id>
    <nct_id>NCT01721421</nct_id>
  </id_info>
  <brief_title>Effects of Extended Haemodialysis Treatment Duration in Patients With End-stage Renal Disease</brief_title>
  <official_title>Feasibility and Physiological and Nutritional Effects of Extended Treatment Duration in Patients With End-stage Renal Disease on Haemodialysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Imperial College London</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Design: Prospective randomised cross-over study. Fifty-two eligible patients will be
      randomised to a treatment time of either 6 hours or 4 hours for a period of 24 weeks and
      following a washout period of 4 weeks, switch to the alternative treatment time for an
      additional 24 weeks.

      Aims: To examine the feasibility and effect of extended dialysis treatment time, 6 hours
      thrice weekly, versus the standard, 4 hours thrice weekly, comparing the differences from
      baseline in outcome measures over a total 12-month period.

      Primary outcome measure

      1]Serum albumin

      Secondary outcome measures Nutritional status

        1. Malnutrition-inflammation score

        2. Dietary intake

        3. Hand-Grip strength

        4. Energy expenditure

      Quality of life

        1. Patient reported quality of life and

        2. time to recovery from dialysis

      Serum biomarkers

        1. BNP

        2. Troponin

        3. MCP-1

      Others 24- hour Ambulatory blood pressure 24-hour accelerometer

      Population: Local haemodialysis population of 1200 patients Eligibility: Minimum 90days on
      haemodialysis treatment Duration: Fifty-six weeks
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">February 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum albumin</measure>
    <time_frame>baseline to 24 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">52</enrollment>
  <condition>End Stage Renal Disease</condition>
  <arm_group>
    <arm_group_label>Extended Treatment time</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Extended treatment time of 6 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>standard treatment time</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard Treatment time of 4 hours</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>extended treatment time</intervention_name>
    <description>patients receive extended dialysis treatment time time of 6 hours</description>
    <arm_group_label>Extended Treatment time</arm_group_label>
    <arm_group_label>standard treatment time</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard treatment time</intervention_name>
    <arm_group_label>Extended Treatment time</arm_group_label>
    <arm_group_label>standard treatment time</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Dialysis dependant for over 90 days

        Exclusion Criteria:

          1. Haemodialysis for less than 90 days

          2. Patients with anticipated life expectancy less than 6 months secondary to significant
             morbidity e.g. metastatic malignancy, advanced human immunodeficiency virus

          3. Patients with acute liver disease; History of underlying haematological condition;

          4. Elective planned change of renal replacement modality within the 12 months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Choi, MBcHB PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Seema Singh</last_name>
    <phone>+44 208 3835249</phone>
    <email>s.singh11@imperial.ac.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Imperial College Healthcare NHS Trust</name>
      <address>
        <city>London</city>
        <zip>W12 0HS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seema Singh, MSc</last_name>
      <phone>+44 2083835249</phone>
      <email>s.singh11@imperial.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Seema Singh, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charles Pusey</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Choi, PhD MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 1, 2012</study_first_submitted>
  <study_first_submitted_qc>November 2, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 5, 2012</study_first_posted>
  <last_update_submitted>November 2, 2012</last_update_submitted>
  <last_update_submitted_qc>November 2, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 5, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>haemodialysis</keyword>
  <keyword>Crossover</keyword>
  <keyword>Treatment time</keyword>
  <keyword>nutritional status</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

